Published in Arzneimittelforschung on January 01, 1985
[Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance]. Arzneimittelforschung (1966) 2.07
BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist. Eur J Pharmacol (1999) 1.38
Relationship between activity and structure in derivatives of clonidine. Arzneimittelforschung (1975) 1.08
Atrial natriuretic factor. Life Sci (1985) 0.95
Evidence for the presence of enkephalins in the heart. Life Sci (1983) 0.95
Highly potent and small neuropeptide Y agonist obtained by linking NPY 1-4 via spacer to alpha-helical NPY 25-36. FEBS Lett (1989) 0.93
A newly developed precise and sensitive radioimmunoassay for clonidine. Arzneimittelforschung (1979) 0.90
Development of a RIA for clonidine and its comparison with the reference methods. J Pharmacol Methods (1981) 0.85
Circadian rhythms of rabbits during restrictive feeding. Am J Physiol (1987) 0.83
A novel cyclic analog of neuropeptide Y specific for the Y2 receptor. Eur J Biochem (1992) 0.82
Development and quality control of a highly sensitive radioimmunoassay for alinidine. J Pharmacol Methods (1981) 0.81
Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy. Mol Pharmacol (1992) 0.81
Restricted food access and light-dark: impact of conflicting zeitgebers on circadian rhythms of the rabbit. Am J Physiol (1993) 0.81
The internal synchronization of five circadian functions of the rabbit. Chronobiol Int (1984) 0.81
Effect of linagliptin (BI 1356) on the steady-state pharmacokinetics of simvastatin. Int J Clin Pharmacol Ther (2010) 0.79
Influence of central pretreatment with 6-hydroxydopamine on the hypotensive effect of clonidine. Arzneimittelforschung (1977) 0.78
Altered neuropeptide concentrations in spontaneously hypertensive rats: cause or consequence? Clin Sci (Lond) (1985) 0.78
Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man. Life Sci (2001) 0.77
Ophthalmological and pharmacological studies after administration of clonidine in rats. Arch Toxicol (1978) 0.77
Possible involvement of cyclic AMP and frontal cortex in amitriptyline mediated suppression of the hypotensive effect of clonidine. Life Sci (1981) 0.77
Proceedings: Relationship between activity and structure in derivative of clonidine. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.77
Neuropeptide Y: identification of the binding site. Int J Pept Protein Res (1990) 0.77
Structure/activity relationships of C-terminal neuropeptide Y peptide segments and analogues composed of sequence 1-4 linked to 25-36. Eur J Biochem (1990) 0.76
Angiotensin stimulates beta-endorphin release from anterior pituitary gland cell cultures of rats. Neurosci Lett (1984) 0.76
Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues. Br J Pharmacol (1996) 0.75
Chemistry, pharmacology, and structure-activity relationships with a new type of imidazolines exerting a specific bradycardic action at a cardiac site. J Med Chem (1980) 0.75
Interactions of MEN 935 (adimolol), a long acting beta- and alpha-adrenolytic antihypertensive agent, with postsynaptic alpha-adrenoceptors in different isolated blood vessels--influence of angiotensin II. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.75
Medicinal chemistry of muscarinic agonists for the treatment of dementia disorders. Eur J Drug Metab Pharmacokinet (1995) 0.75
Evidence against co-storage of enkephalins with noradrenaline in bovine adrenal medullary granules. Eur J Pharmacol (1982) 0.75
Characterization of the binding site of neuropeptide Y to the rabbit kidney receptor using multiple peptide synthesis. Biochem Soc Trans (1992) 0.75
[Effect of 2,6-dichlorphenylamino-imidazoline-HCl on blood pressure and plasma renin activity in rats]. Pflugers Arch (1969) 0.75
The influence of metabolic degradation on the blood pressure lowering effect of clonidine in rabbits after different routes of administration. Arzneimittelforschung (1985) 0.75
Mechanisms of antihypertensive action of clonidine in relation to its psychotropic effects. Prog Clin Biol Res (1981) 0.75
[Pharmacological effects of a new antihypertensive agent with imidazoline structure]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.75
Synthesis and hypotensive activity of some analogs of the C-terminal hexapeptideamide of eledoisin. Arzneimittelforschung (1980) 0.75
The on column methylation of clonidine and p-hydroxyclonidine with trimethylanilinium hydroxide. Biomed Mass Spectrom (1978) 0.75
Pharmacokinetics and pharmacodynamics of BIBT 986, a novel small molecule dual inhibitor of thrombin and factor Xa. J Thromb Haemost (2006) 0.75
[Action and mechanism of action of clonidine]. Buch Augenarzt (1974) 0.75
Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulation. Clin Pharmacol Ther (2007) 0.75
Influence of desmethylimipramine on the hypotensive effect of clonidine. Arzneimittelforschung (1974) 0.75
The bioactive conformation of neuropeptide Y analogues at the human Y2-receptor. Eur J Biochem (1997) 0.75
Postjunctional alpha-adrenoceptors and influence of angiotensin II in different isolated blood vessels. Arzneimittelforschung (1985) 0.75
General pharmacology of brotizolam in animals. Arzneimittelforschung (1986) 0.75
Blood pressure lowering action and alpha-adrenolytic effect of adimolol in rats. Arch Int Pharmacodyn Ther (1990) 0.75
Cyclopeptide analogs for characterization of the neuropeptide Y Y2-receptor. J Recept Res (1993) 0.75
Alpha-helical small molecular size analogues of neuropeptide Y: structure-activity relationships. Biopolymers (1991) 0.75
Mr 2033 CL--a novel non-morphine-like opioid analgesic. NIDA Res Monogr (1983) 0.75
A sleep-like state in chicks caused by biogenic amines and other compounds; quantitative evaluation. Arzneimittelforschung (1971) 0.75
Crystal and molecular structure of 2-[N-allyl-N-(2,6-dichlorophenyl)amino]-2-imidazoline hydrobromide. Arch Pharm (Weinheim) (1987) 0.75
[Problems in preclinical pharmacology when deciding on suitable animal species and animal tests models]. Arzneimittelforschung (1977) 0.75
Tissue concentrations of opioid peptides in rats do not depend on blood pressure height. Clin Exp Hypertens A (1984) 0.75